EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi

Anuj Narwal, Claire S Whyte, Nicola J Mutch

Frontiers in Cardiovascular Medicine · 18.01.2023 · 9

DOI: 10.3389/fcvm.2022.1070502 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 18.01.2023. Verfasst von Anuj Narwal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Aberdeen Cardiovascular and Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdee…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombi are heterogenous in nature with composition and structure being dictated by the site of formation, initiating stimuli, shear stress, and cellular influences. Arterial thrombi are historically associated with high platelet content and more tightly packed fibrin, reflecting the shear stress in these vessels. In contrast, venous thrombi are generally erythrocyte and fibrin-rich with reduced platelet contribution. However, these conventional views on the composition of thrombi in divergent vascular beds have shifted in recent years, largely due to recent advances in thromboectomy and high-resolution imaging. Interestingly, the distribution of fibrinolytic proteins within thrombi is directly influenced by the cellular composition and vascular bed. This in turn influences the susceptibility of thrombi to proteolytic degradation. Our current knowledge of thrombus composition and its impact on resistance to thrombolytic therapy and success of thrombectomy is advancing, but nonetheless in its infancy. We require a deeper understanding of thrombus architecture and the downstream influence on fibrinolytic susceptibility. Ultimately, this will aid in a stratified and targeted approach to tailored antithrombotic strategies in patients with various thromboembolic diseases.

Schlagwörter

Stichwörter der Autor:innen

fibrinfibrinolysisplasminogen activatorsplateletsthrombus

Autor:innen und Institutionen

  • Aberdeen Cardiovascular and Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.

Förderung

  • British Heart Foundation

Zitieren

APA

Narwal, A., Whyte, C. S., & Mutch, N. J. (2023). Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1070502

Vancouver

Narwal A, Whyte CS, Mutch NJ. Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi. Frontiers in Cardiovascular Medicine. 2023;9. doi:10.3389/fcvm.2022.1070502

BibTeX
@article{Narwal2023,
  author = {Narwal, Anuj and Whyte, Claire S and Mutch, Nicola J},
  title = {Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {9},
  doi = {10.3389/fcvm.2022.1070502}
}
Kostenlos starten →